Transitioning to a national health system in Cyprus: a stakeholder analysis of pharmaceutical policy reform.
about
Cost-Sharing Rates Increase During Deep Recession: Preliminary Data From GreeceAddressing the challenge of high-priced prescription drugs in the era of precision medicine: A systematic review of drug life cycles, therapeutic drug markets and regulatory frameworks.Comparing Generic Drug Markets in Europe and the United States: Prices, Volumes, and Spending.
P2860
Transitioning to a national health system in Cyprus: a stakeholder analysis of pharmaceutical policy reform.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Transitioning to a national he ...... pharmaceutical policy reform.
@ast
Transitioning to a national he ...... pharmaceutical policy reform.
@en
type
label
Transitioning to a national he ...... pharmaceutical policy reform.
@ast
Transitioning to a national he ...... pharmaceutical policy reform.
@en
prefLabel
Transitioning to a national he ...... pharmaceutical policy reform.
@ast
Transitioning to a national he ...... pharmaceutical policy reform.
@en
P2860
P356
P1476
Transitioning to a national he ...... f pharmaceutical policy reform
@en
P2093
Panos G Kanavos
P2860
P304
P356
10.2471/BLT.14.148742
P407
P577
2015-06-18T00:00:00Z